Picture of PhoenixBio logo

6190 — PhoenixBio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Table: Phoenixbio - 6-MTH group results

Nov 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            426 mln             316 mln            1.28      
                 (+34.9 pct)         (-43.3 pct)       (+41.5 pct)  
  Operating     loss 265 mln        loss 226 mln      loss 124 mln  
  Recurring     loss 249 mln        loss 220 mln      loss 113 mln  
  Net           loss 251 mln        loss 221 mln      loss 129 mln  
  EPS          loss 86.18 yen      loss 76.49 yen    loss 44.45 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T

Recent news on PhoenixBio

See all news